Incident and Prevalent Use of Generic Drugs for Overactive Bladder

    Basic Details
    Date Posted
    Monday, December 11, 2017
    Status
    In progress
    Medical Product
    darifenacin hydrobromide
    fesoterodine fumarate
    oxybutynin chloride
    solifenacin succinate
    tolterodine tartrate
    trospium chloride
    Description

    These reports examine the prevalent and incident use of six drug products used for overactive bladder in the Mini-Sentinel Distributed Database (MSDD). Results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on June 4, 2013 to 17 Data Partners; this report includes information from 17 Data Partners.

    Additional Details
    FDA Center
    CDER
    Time Period
    2001 - 2012
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)